Xeltis Successfully Passes Evaluation Phase for €10Mil Investment from European Innovation Council
Funding to support commercialization of its groundbreaking bioresorbable vascular conduits notes Xeltis.
April 8, 2025
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Funding to support commercialization of its groundbreaking bioresorbable vascular conduits notes Xeltis.
The BDD facility will provide cost-effective manufacturing and clinical testing for pharma and contract research organisations of all sizes.
This raise reflects accelerating market conviction that healthcare advocacy is a critical standard of care that drives better outcomes, lowers costs, and enhances patient experiences notes Solace.